XEMPLAR

Serial Number 87898615
Registration 5801704
700

Registration Progress

Application Filed
Apr 28, 2018
Under Examination
Nov 27, 2018
Approved for Publication
Oct 2, 2018
Published for Opposition
Oct 2, 2018
Registered
Jul 9, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-07-09) (Grace Period Filing)
Due: Jan 09, 2026 Grace Period - 164 days
Original deadline was Jul 09, 2025 (overdue)

Trademark Image

XEMPLAR

Basic Information

Serial Number
87898615
Registration Number
5801704
Filing Date
April 28, 2018
Registration Date
July 9, 2019
Published for Opposition
October 2, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 9, 2019
Registration
Registered
Classes
042

Rights Holder

xCella Biosciences, Inc.

03
Address
1490 O'Brien Dr, Suite C
Menlo Park, CA 94025

Ownership History

xCella Biosciences, Inc.

Original Applicant
03
Menlo Park, CA

xCella Biosciences, Inc.

Owner at Publication
03
Menlo Park, CA

xCella Biosciences, Inc.

Original Registrant
03
Menlo Park, CA

Legal Representation

Attorney
Jenny Lee

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-07-09)
Due Date
July 09, 2025
Grace Period Ends
January 09, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
Jul 9, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jul 9, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 7, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jun 6, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
May 17, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 17, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 16, 2019 ALIE A ASSIGNED TO LIE Loading...
May 9, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 20, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 20, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 20, 2019 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Feb 7, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 7, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 11, 2019 IUAF S USE AMENDMENT FILED Loading...
Jan 11, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 27, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 2, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 2, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 12, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 27, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 20, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
May 8, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 2, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific, biological, and medical research; consulting services in the fields of biotechnology, pharmaceutical research and development, and design and development of proteins, enzymes, biologics, and drug formulations; scientific and technological services, namely, research in the fields of chemistry and molecular biology, namely, protein and biologics detection, characterization, analysis and testing; research and development services in connection with the design, synthesis and assembly of nucleic acids, peptides, proteins, cells, nucleic acid arrays, peptide arrays, and protein arrays
First Use Anywhere: Apr 5, 2019
First Use in Commerce: Apr 5, 2019

Additional Information

Pseudo Mark
EXEMPLAR

Classification

International Classes
042